Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Common Equity (2016 - 2026)

Metlife's Common Equity history spans 18 years, with the latest figure at $27.3 billion for Q1 2026.

  • Quarterly Common Equity fell 1.55% to $27.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $27.3 billion through Mar 2026, down 1.55% year-over-year, with the annual reading at $28.4 billion for FY2025, 2.51% up from the prior year.
  • Common Equity came in at $27.3 billion for Q1 2026, down from $28.4 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $42.7 billion in Q1 2022 to a low of $25.9 billion in Q3 2023.
  • The 5-year median for Common Equity is $29.2 billion (2025), against an average of $30.1 billion.
  • Year-over-year, Common Equity tumbled 57.25% in 2022 and then grew 20.35% in 2024.
  • Metlife's Common Equity stood at $30.1 billion in 2022, then grew by 0.42% to $30.3 billion in 2023, then dropped by 8.43% to $27.7 billion in 2024, then grew by 2.51% to $28.4 billion in 2025, then fell by 3.78% to $27.3 billion in 2026.
  • Per Business Quant, the three most recent readings for MET's Common Equity are $27.3 billion (Q1 2026), $28.4 billion (Q4 2025), and $29.2 billion (Q3 2025).